Latest News
Institutional support, federal funding, philanthropy and grants are the support that make cancer research possible.
- FEATUREDFebruary 28, 2024
Yale Cancer Center has a long history of breakthrough cancer research and is perhaps best known as the institution where cancer chemotherapy and the entire field of cancer drug development was discovered and the very first cancer drug was administered in 1942. Dr. William Gardner's studies on steroid hormones and their role in experimental carcinogenesis added another dimension to our understanding of malignant disease. The first FDA approved selective immunotherapy treatment for any type of cancer, Transimmunization, was also developed at Yale under the direction of Dr. Richard Edelson.
- FEATUREDFebruary 28, 2024
Yale Cancer Center and Smilow Cancer Hospital people who have been honored
- March 28, 2024
On March 27, 2024, members of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center presented in honor of Colorectal Cancer Awareness Month.
- March 28, 2024
Theodore “Ted” Hovey made a conscious decision while battling multiple myeloma that he would largely do it by himself. He went unaccompanied to his appointments – “I don’t want to have to entertain the person who’s there with me” – and took on the cancer one-on-one. But from his visits to Yale Cancer Center and Smilow Cancer Hospital, Ted, 59, who’s spent most of his working life in the marine industry, quickly learned that he wasn’t alone.
- March 27, 2024Source: The New York Times
“It’s unfortunately becoming a bigger problem every year,” said Dr. Michael Cecchini, a co-director of the colorectal program in the Center for Gastrointestinal Cancers and a medical oncologist at Yale Cancer Center. He added that early-onset colorectal cancers have been increasing by about 2 percent per year since the mid-1990s.
- March 27, 2024Source: Hospice News
Dr. Elizabeth Horn Prsic is a medical oncologist and palliative care physician. She serves as the director of adult inpatient palliative care at the Yale School of Medicine in Connecticut. Horn Prsic is also the firm chief of medical oncology and education at the Smilow Cancer Hospital and Yale New Haven Hospital.
- March 26, 2024Source: New York Post
Dr. Veda Giri, a Yale Medicine medical oncologist and director of Yale Cancer Center’s Early-Onset Cancer Program at Smilow Cancer Hospital, said this month that the prevalence of early-onset cancer “points to the need for more research in all kinds of domains — in population science, behavioral health, public health, and basic science as well.”
- March 26, 2024Source: WTNH News 8
In today’s health headlines, what to know about chemotherapy, is it being replaced with immunotherapy and how often does cancer get detected during treatment for other conditions? Gynecologic oncologist and co-chief of the gynecologic oncology section at Yale Cancer Center, Dr. Elena Ratner, joined News 8 to discuss these topics.
- March 25, 2024
The Yale Pathology Research in Progress series provides students with feedback that helps improve their research projects and presentations.